BodyComp™ Analysis
Body composition, weight‑management, GLP‑1 therapy monitoring
CommercialActive
Key Facts
Indication
Body composition, weight‑management, GLP‑1 therapy monitoring
Phase
Commercial
Status
Active
Company
About ImpediMed
Australian med‑tech firm delivering FDA‑cleared BIS diagnostics for fluid‑status monitoring across oncology, cardiology and metabolic care.
View full company profile